Spectrum Pharmaceuticals Total Liabilities

Spectrum Pharmaceuticals (SPPI) currently reports a total liabilities of $81M as of March 2023. That compares with $45M in the prior-year period — up 80.5% year over year. Use the charts on this page to explore Spectrum Pharmaceuticals's total liabilities history and peer comparisons.

Spectrum Pharmaceuticals's total liabilities increased from $45M to $81M — a 80.5% year-over-year increase (period ending March 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Spectrum Pharmaceuticals reported $81M in total liabilities as of March 2023. That compares with $45M in the prior-year period — up 80.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $81M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Spectrum Pharmaceuticals, and consider following SPPI for alerts when major investors trade the stock.

Spectrum Pharmaceuticals is classified in the Healthcare sector. On total liabilities, it currently shows $81M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SPPI with unrelated industries.